AI assistant
Avalon GloboCare Corp. — Director's Dealing 2018
Jan 19, 2018
35245_dirs_2018-01-19_d517e1fd-2861-42d7-8295-2c5770108725.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Avalon Globocare Corp. (AVCO)
CIK: 0001630212
Period of Report: 2017-12-15
Reporting Person: Sukel Steven Philip (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-15 | Common Stock, $.0001 par value | P | 600 | $2.67 | Acquired | 217315 | Direct |
| 2018-01-17 | Common Stock, $.0001 par value | P | 300 | $2.00 | Acquired | 217515 | Direct |
| 2018-01-17 | Common Stock, $.0001 par value | P | 100 | $2.60 | Acquired | 217615 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $1.49 | 2022-04-01 | Common Stock (30000) | 30000 | Direct |
Footnotes
F1: Mr. Sukel is entitled to receive options to receive 40,000 shares of common stock per year at an exercise price equal to the closing price on December 31st of the prior year. The options shall vest in equal amounts quarterly and shall be exercisable for a period of five years. The options for 2017 have been pro-rated. As result, Mr. Sukel received a stock option to acquire 30,000 shares of common stock at an exercise price of $1.49 per share for a term of five years vesting 10,000 shares at the beginning of each quarter commencing April 1, 2017.